What is the recommended dosing for Venlafaxine (Effexor) Extended Release (ER)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Venlafaxine ER Dosing

Start venlafaxine ER at 37.5 mg once or twice daily, increase by 75 mg weekly to a target of 150-225 mg/day, with a maximum of 375 mg/day if needed for severe depression. 1

Starting Dose

  • Begin at 37.5 mg once or twice daily 1
  • The FDA-approved immediate-release formulation starts at 75 mg/day in divided doses, but extended-release allows for lower initial dosing 2
  • Lower starting doses (37.5 mg) reduce initial nausea, the most common side effect 3

Titration Schedule

  • Increase by 75 mg each week as tolerated 1
  • Allow minimum 4-day intervals between dose increases 2
  • Titration to therapeutic effect typically requires 2-4 weeks 1

Target Therapeutic Dose

  • 150-225 mg/day is the efficacious range for most indications including neuropathic pain and depression 1
  • For major depression, 75-225 mg/day demonstrates significant efficacy over placebo 3
  • The majority of patients respond adequately to doses ≤225 mg/day 4

Maximum Dose

  • Maximum 225 mg/day for routine outpatient depression 1
  • Up to 375 mg/day may be used in severely depressed inpatients or treatment-resistant cases 2, 4
  • Higher doses (>300 mg/day) show additional benefit in severely ill patients but carry increased risk of dose-dependent blood pressure elevation 4, 5

Duration of Adequate Trial

  • Allow 4-6 weeks at target dose to assess response 1
  • Some patients show early response by week 1-2, particularly at higher doses 5

Special Population Adjustments

Hepatic Impairment

  • Reduce total daily dose by 50% in mild to moderate hepatic impairment 2
  • Individual variability may require greater reduction; monitor closely 2

Renal Impairment

  • Reduce total daily dose by 25% for GFR 10-70 mL/min 2
  • Reduce by 50% in patients on hemodialysis 2

Elderly Patients

  • No specific dose adjustment required based on age alone 2
  • Use caution with dose escalation; consider lower starting doses and slower titration 1

Critical Safety Considerations

Cardiovascular Monitoring

  • Monitor blood pressure at doses >150 mg/day 1
  • Dose-dependent hypertension occurs in 3-5% at ≤200 mg/day, 7% at 201-300 mg/day, and 13% at >300 mg/day 5
  • Use with caution in cardiac disease due to reports of cardiac conduction abnormalities 1

Discontinuation

  • Always taper gradually when stopping; never discontinue abruptly 1, 2
  • Withdrawal syndrome is well-documented with venlafaxine 1
  • If intolerable symptoms occur during taper, resume previous dose and decrease more gradually 2

MAOI Interactions

  • Wait 14 days after stopping MAOI before starting venlafaxine 2
  • Wait 7 days after stopping venlafaxine before starting MAOI 2

Common Pitfalls to Avoid

  • Do not start at 75 mg in ER formulation—this increases nausea and early discontinuation; 37.5 mg is better tolerated 1, 3
  • Do not increase doses faster than weekly intervals—this increases adverse effects without improving efficacy 1, 2
  • Do not exceed 225 mg/day in outpatients without clear rationale—higher doses increase blood pressure risk without consistent additional benefit 1, 4, 5
  • Do not forget to taper—abrupt discontinuation causes withdrawal syndrome 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.